Constellium Reports Record Q1 Results, Net Income Up 416%, and Raises Full-Year Guidance
summarizeSummary
Constellium SE reported record first-quarter financial results, with net income surging 416% and Adjusted EBITDA up 93%, leading to a significant raise in its full-year 2026 guidance.
check_boxKey Events
-
Record Q1 Financial Performance
Net income increased by 416% to $196 million, and Adjusted EBITDA rose 93% to $359 million, marking a record quarter for the company and its operating segments.
-
Raised Full-Year 2026 Guidance
The company raised its 2026 Adjusted EBITDA guidance to a range of $900 million to $940 million and expects Free Cash Flow in excess of $275 million.
-
Active Share Repurchase Program
Constellium repurchased 1.2 million shares of its stock for $28 million during the first quarter, actively returning capital to shareholders under its existing program.
-
Strong Balance Sheet and Liquidity
The company maintained a healthy leverage ratio of 2.2x, within its target range, and reported liquidity of $904 million at quarter-end.
auto_awesomeAnalysis
Constellium SE delivered exceptionally strong first-quarter results, significantly surpassing prior year performance with a 416% increase in net income and a 93% rise in Adjusted EBITDA. This robust performance, which included record quarterly Segment Adjusted EBITDA, has led the company to raise its full-year 2026 guidance for both Adjusted EBITDA and Free Cash Flow. The positive financial trajectory is supported by favorable market dynamics, including supply shortages in automotive rolled products and an improved aerospace environment, building on the recent multi-year agreement with Airbus. The company also actively returned capital to shareholders by repurchasing $28 million in stock during the quarter, demonstrating confidence in its financial health and strategic execution. These strong results come as the stock trades near its 52-week high, providing fundamental justification for the market's positive sentiment.
At the time of this filing, CSTM was trading at $32.97 on NYSE in the Manufacturing sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $9.07 to $31.61. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.